Quadrant Capital Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,946
| Closed | -$48.9K | – | 1340 |
|
|
2025
Q1 | $48.9K | Sell |
21,946
-32,763
| -60% | -$73.1K | ﹤0.01% | 1723 |
|
|
2024
Q4 | $160K | Buy |
54,709
+24,871
| +83% | +$72.9K | 0.01% | 801 |
|
|
2024
Q3 | $77.6K | Buy |
29,838
+28,786
| +2,736% | +$74.8K | 0.01% | 1222 |
|
|
2024
Q2 | $3.11K | Buy |
1,052
+604
| +135% | +$1.79K | ﹤0.01% | 2405 |
|
|
2024
Q1 | $2.03K | Sell |
448
-1,555
| -78% | -$7.05K | ﹤0.01% | 2505 |
|
|
2023
Q4 | $11.4K | Buy |
2,003
+1,121
| +127% | +$6.4K | ﹤0.01% | 2015 |
|
|
2023
Q3 | $4.06K | Hold |
882
| – | – | ﹤0.01% | 2226 |
|
|
2023
Q2 | $5.7K | Buy |
+882
| New | +$5.7K | ﹤0.01% | 2175 |
|